TVM's Canadian flavor

Teralys Capital, Eli Lilly go for new TVM biotech fund in Canada

TVM's Canadian flavor

Canadian fund-of-funds investor Teralys Capital made its second life sciences commitment this year, putting $65 million into an initial $150 million close for TVM Life Science Ventures VII.

Teralys has $700 million under management

Read the full 356 word article

How to gain access

Continue reading with a
two-week free trial.